MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Definium Therapeutics, Inc. (DFTX)
Definium Therapeutics, Inc. (DFTX)
source: myfinsight.com
Comprehensive loss
-$77,359K
Gain/(loss) on foreign
currency translation
$1K
Net loss
-$77,098K
Unrealized gain/(loss) on
investments
-$262K
Loss from operations
-$59,220K
Total other
income/(expense)
-$17,878K
Interest income
$3,457K
Total operating
expenses
$59,220K
Change in fair value of
2022 usd financing...
$20,046K
Interest expense
$1,245K
Foreign exchange loss,
net
-$44K
Research and development
$41,484K
General and
administrative
$17,736K
Back